Published 9 June 2009, doi:10.1136/bmj.b2334
Cite this as: BMJ 2009;338:b2334

Letters

Homoeopathic product licence

Being useless may be useful

The first 150 words of the full text of this article appear below.

Giving homoeopathy credit for any kind of demonstrable efficacy is ludicrous, and we all know it.1

However, a good placebo is an incredibly useful (and powerful) therapeutic tool, which should only be used with caution.2 In this context, and when there is a need to give something more to a patient than just good words, a truly inactive placebo, with little risk of harm, might actually be useful, if only to avoid giving more dangerous but still useless drugs.

The first indication the NHS should consider for homoeopathy is the common cold followed by acute sinusitis (if it doesn’t get better within a week, then use antibiotics), insomnia (as effective as benzodiazepines after two weeks, and much less addictive), and any number of uselessly overtreated illnesses. It should be offered in a choice of colours appropriate to the indication,3 the content being irrelevant, with clear indications that this will not . . . [Full text of this article]

Nicholas Moore, clinical pharmacologist1

1 University of Bordeaux, 33076 Bordeaux, France

nicholas.moore@pharmaco.u-bordeaux2.fr


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Drugs agency grants its first licence to homoeopathic product
Deborah Cohen
BMJ 2009 338: b2055. [Extract] [Full Text]

Placebos in medicine: Placebo use is well known, placebo effect is not
Toke S Barfod
BMJ 2005 330: 45. [Extract] [Full Text]




Access jobs at BMJ Careers
Whats new online at Student 

BMJ